Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Is It Advisable To Add Fifth Third (FITB) To Your Portfolio?

Published 01/07/2018, 09:13 PM
Updated 07/09/2023, 06:31 AM
US500
-
FITB
-
FHI
-
LM
-
APAM
-

Improving operating backdrop, rising rate environment, anticipated tax benefit from the U.S. tax reform and the strengthening domestic economy are projected to continue supporting banking stocks. Keeping this in mind, we have selected Fifth Third Bancorp (NASDAQ:FITB) for your portfolio.

It’s a good idea to add stocks with robust fundamentals and long-term growth opportunities to your portfolio, at the current level. Fifth Third is one such stock that has been witnessing upward estimate revisions, reflecting analysts’ optimism about its future prospects. Over the last 30 days, the Zacks Consensus Estimate for 2017 and 2018 jumped 5.5% and 3%, respectively.

Further, shares of this Zacks Rank #2 (Buy) company have gained around 16.6% in six months’ time, outperforming 12.6% growth recorded by the industry.



Fifth Third has a number of other aspects that make it an attractive investment option.

Why Fifth Third is a Must Buy

Organic Growth: Fifth Third’s diverse revenue base will likely support its earnings growth. The company has expanded its non-interest income base, which now represents over 48% of total revenues in the first nine months of 2017. Furthermore, management expects fee income to increase in the near term. Additionally, the company remains focused on executing measures, including branch consolidation.

Earnings Strength: Fifth Third recorded earnings growth rate of 2.1% over the last three to five years. Also, earnings are expected to display an upswing in the near term, as the company’s projected EPS growth (3-5 years) is 6.7%. Also, Fifth Third recorded an average positive earnings surprise of 5.29%, over the trailing four quarters.

Stock is Undervalued: Fifth Third has P/E and P/B ratios of 14.9 and 1.44 compared to the S&P 500 average of 19.11 and 3.4, respectively. Based on these ratios, the stock seems undervalued.

Other Stocks to Consider

Legg Mason Inc. (NYSE:LM) has been witnessing upward estimate revisions for the past seven days. Also, the company’s shares have returned nearly 6.7% over the past six months. It flaunts a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Federated Investors Inc. (NYSE:FII) has been witnessing upward estimate revisions for the last 60 days. The company’s shares have appreciated 23.5% in six months. It carries a Zacks Rank of 2.

Artisan Partners Asset Management Inc. (NYSE:APAM) has been witnessing upward estimate revisions for the past two months. Additionally, the stock has rallied more than 25% in six months. It currently carries a Zacks Rank of 2.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Fifth Third Bancorp (FITB): Free Stock Analysis Report

Legg Mason, Inc. (LM): Free Stock Analysis Report

Federated Investors, Inc. (FII): Free Stock Analysis Report

Artisan Partners Asset Management Inc. (APAM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.